Senate advances cannabis-regulation bill, adopts oversight, testing, delivery and tax-study amendments

The Massachusetts Senate considered and amended a measure restructuring the Cannabis Control Commission and related cannabis regulations, adopting oversight, testing and delivery changes while rejecting several other proposals.

The chamber adopted an amendment preserving commissioners’ ability to receive complaints and operational information (Amendment 3), a provision requiring annual review of testing protocols (Amendment 6), a redraft allowing delivery of cannabis into localities that previously barred retail sales with a two‑year waiver option (Amendment 17), and a requirement that the Cannabis Control Commission study the effect of state taxes and fees on licensed businesses and the illicit market (Amendment 43). Several other amendments — including tighter warning-label language (Amendment 9), a proposal to restore a five‑member commission with a different appointment method (Amendment 25), and proposals to create a self‑exclusion program and change certain tax allocations — failed to pass.

Why it matters: supporters framed the adopted oversight and testing measures as steps to bolster public‑health protections, worker safety and regulatory consistency as the state continues to implement legalization. Opponents argued some proposals would politicize appointments or duplicate existing protections.

Senator John F. Keenan, sponsor of an earlier amendment he later withdrew, corrected the record during debate: “My response was inaccurate … I apologize for that,” he said, clarifying he had misspoken about whether changing possession thresholds would send more people to treatment or to awareness programs. Keenan withdrew his amendment by unanimous consent.

A central piece of floor debate concerned commissioners’ access to operational information. Senator Michael O’Moore (Mr. Moore) described a string of problems that, he said, support preserving that access: “To begin with, in January 2022, a cannabis worker suffered a tragic death at a cannabis facility. At that time, the commissioners did not learn about this death until allegedly October 2022,” he said, and added that “in 2023, the CCC inadvertently released data on approximately tens of thousands of cannabis employees’ personal data.” Moore made several other assertions about the agency’s operations, including past mediation costs and an open‑meeting‑law finding; the chamber adopted his amendment (recorded tally: 37 in the affirmative, none in the negative).

Senator Patricia D. Jalen, sponsor of the tax‑study amendment, asked the CCC to investigate whether the combined tax and fee structure affects licenced businesses’ competitiveness against the illicit market and the viability of social‑equity businesses. She noted the voter‑approved ballot initiative established a 12% maximum tax in a prior measure and that subsequent legislative proposals had varied; the Senate package reflected a negotiated rate structure that sponsors said merits study.

Senator James O’Connor proposed detailed consumer warning labels for THC products that would state the products have not been analyzed or approved by the Food and Drug Administration and advise against use during pregnancy or when operating machinery. He said the goal is consumer protection; opponents said the bill already contains robust labeling language. The amendment was defeated on a roll call (11 yeas, 26 nays).

Other outcomes: sponsors withdrew some amendments to allow further work outside the chamber; a number of proposed changes were placed on hold for later consideration. The Senate also handled House measures during the session: a bill allowing the town of Palmer additional alcoholic‑beverage licenses was announced passed to be enacted, and the Senate adopted an emergency preamble for a House bill authorizing easements to the city of Lowell.

What happens next: the bill will continue through the legislative process with the adopted amendments incorporated unless further changes occur in committee or on a subsequent floor action. The most recent formal roll‑call tallies available from the session show recorded adoption of Amendment 3 (37–0), adoption of Amendments 6, 17 and 43 by voice votes, and defeat of Amendments 9 (11–26) and 25 (8–29).

Votes at a glance • Amendment 3 (preserve commissioners’ receipt of complaints/whistleblower access): adopted; recorded 37 yeas, 0 nays (block evidence: SEG 532–SEG 738). • Amendment 6 (annual review of testing protocols): adopted by voice vote (SEG 482–SEG 530). • Amendment 17 (delivery; local waiver process): adopted by voice vote (SEG 744–SEG 779). • Amendment 43 (tax‑impact study for CCC): adopted by voice vote (SEG 261–SEG 328). • Amendment 9 (expanded consumer warning labels): defeated by roll call, 11 yeas, 26 nays (SEG 786–SEG 1061). • Amendment 23 (self‑exclusion program): not adopted on voice vote (SEG 171–SEG 201). • Amendment 24 (require DMH/DPH collaboration on health study): not adopted on voice vote (SEG 202–SEG 232). • Amendment 25 (restore five commissioners / change appointment method): defeated by roll call, 8 yeas, 29 nays (SEG 1062–SEG 1332).

Key authorities and references in the debate included a statutory reference to section 42 of chapter 23K (self‑exclusion program model) and a citation to the state’s existing appointment language in Mass. Gen. Laws ch. 10, §76 (appointment process for some commissioners). The Senate record shows sponsors requested some amendments be held for later consideration, and several brief recesses interrupted floor action.

Sources: Senate floor proceedings (debate and roll calls) as transcribed in the session record. The article quotes statements made on the floor attributed to Senators present in the hearing record.